SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

Jun 23, 2016 at 17:48 | Source: Reuters
The world's fifth-largest maker of generic drugs was the first among its Indian peers to enter the roughly USD 5 billion US dermatology space by acquiring a controlling stake in Israel's Taro Pharmaceutical Industries Ltd in 2010.
Jun 22, 2016 at 15:02 | Source: Moneycontrol.com
Mesco Pharmaceuticals Ltd has informed BSE that Mr. Pawan Sharma is been appointed as Company Secretary and Compliance Officer of the Company w.e.f. March 15, 2016 pursuant to section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Jun 21, 2016 at 15:04 | Source: Moneycontrol.com
Alembic Pharmaceuticals Ltd has informed BSE that the 6th Annual General Meeting (AGM) of the Company will be held on July 29, 2016.
Jun 20, 2016 at 15:46 | Source: CNBC-TV18
Madhu Kela of Reliance Capital firmly believes there is huge amount of money, both with local and global investors, waiting on the sidelines and investments will begin as earnings growth gathers momentum and monsoon pans out as expected.
Jun 16, 2016 at 11:49 | Source: Moneycontrol.com
Makers Laboratories Ltd has informed BSE that Ms. Khushbu Thakkar, Company Secretary has resigned from the services of the Company w.e.f. close of business hours on June 15, 2016.
Jun 15, 2016 at 15:39 | Source: Moneycontrol.com
Sharon Bio-Medicine Ltd has informed BSE that Mr. Viral Dilip Vora, being Company Secretary in whole time in employment has resigned as a Company Secretary as well as Compliance Officer of the Company w.e.f. May 31, 2016.
Jun 14, 2016 at 19:16 | Source: Moneycontrol.com
A Moneycontrol survey picks stocks in which foreign instituitional investors (FIIs) and mutual funds (MFs) have been continuously increasing and offloading their stake in the last five quarters.
Jun 14, 2016 at 15:22 | Source: Moneycontrol.com
Themis Medicare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 17, 2016,, to consider the allotment of 5,00,000 Equity Shares of Rs 10 each at a price of Rs 500 each to Non Promoters to be issued on preferential basis.
Jun 13, 2016 at 15:30 | Source: Moneycontrol.com
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 13, 2016, has approved appointment of Ms. Monaz Noble as Additional Director on the Board of Directors of the Company w.e.f June 13, 2016 to hold the office of Additional Director upto the date of Annual General Meeting.
Jun 13, 2016 at 14:49 | Source: Moneycontrol.com
Trans Asia Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 13, 2016, approved the opening of Current Account with IDFC Bank, Mumbai.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

12.06 PM May 16th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

12.18 PM Apr 17th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

3.55 PM Mar 26th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

2.00 PM Mar 25th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

4.39 PM Mar 13th 2014

vk1939

Platinum Member

213 Followers

GlaxoSmithKline  

7.08 PM Feb 18th 2014

yrfriend007

Platinum Member

196 Followers

GlaxoSmithKline  

3.51 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

2.00 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

14298 Followers

GlaxoSmithKline  

1.51 PM Feb 18th 2014

kabiroberoi
90

New Member

0 Follower

GlaxoSmithKline  

1.04 PM Feb 18th 2014

News across the web »
Feb 18, 2014 at 10:41 | Source: Economic Times
Feb 18, 2014 at 08:26 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.